rs568612627
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM1PM5PP2PP3_ModeratePP5_Very_Strong
The NM_004004.6(GJB2):c.533T>C(p.Val178Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000929 in 1,614,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V178L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_004004.6 missense
Scores
Clinical Significance
Conservation
Publications
- Bart-Pumphrey syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- ichthyosis, hystrix-like, with hearing lossInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- keratoderma hereditarium mutilansInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
- palmoplantar keratoderma-deafness syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
- autosomal recessive nonsyndromic hearing loss 1AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, PanelApp Australia
- hearing loss, autosomal recessiveInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- autosomal dominant keratitis-ichthyosis-hearing loss syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics
- autosomal dominant nonsyndromic hearing loss 3AInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- KID syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GJB2 | ENST00000382848.5 | c.533T>C | p.Val178Ala | missense_variant | Exon 2 of 2 | 1 | NM_004004.6 | ENSP00000372299.4 | ||
| GJB2 | ENST00000382844.2 | c.533T>C | p.Val178Ala | missense_variant | Exon 1 of 1 | 6 | ENSP00000372295.1 | |||
| ENSG00000296095 | ENST00000736390.1 | n.232-3469T>C | intron_variant | Intron 1 of 3 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152208Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251290 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461808Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727194 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152326Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74500 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 1A Pathogenic:2
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
not provided Pathogenic:2
This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 178 of the GJB2 protein (p.Val178Ala). This variant is present in population databases (rs568612627, gnomAD 0.02%). This missense change has been observed in individuals with autosomal recessive non-syndromic deafness (PMID: 11439000, 21392827, 25189242). ClinVar contains an entry for this variant (Variation ID: 550961). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GJB2 protein function with a positive predictive value of 95%. This variant disrupts the p.Val178 amino acid residue in GJB2. Other variant(s) that disrupt this residue have been observed in individuals with GJB2-related conditions (PMID: 28405014), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25447126, 21392827, 25218342, 18368581, 29140768, 16125251, 25388846, 36048236, 11439000, 25189242, 31620164) -
Nonsyndromic genetic hearing loss Pathogenic:1
Variant summary: GJB2 c.533T>C (p.Val178Ala) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251290 control chromosomes. c.533T>C has been reported in the literature as a homozygous/compound heterozygous genotype in cohorts of individuals affected with hearing impairment and/or sensorineural hearling loss (SNHL) (example, Hamelmann_2001, Tang_2006, Kabahuma_2011, Neocleous_2014). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic citing overlapping evidence utilized in the context of this evaluation. Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at